Search

everythinglearnresearchcommunity

for

Search:↓

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Ayurvedic plants may help treat PCOD by affecting hormones and ovarian health.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

New treatments for male hypogonadism are effective and should be personalized.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Women with PCOS have altered brain structure and reduced cognitive performance.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Epithelial-mesenchymal interactions control hair growth cycles through specific molecular signals.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Blocking testosterone speeds up wound healing in males.